Ang Cui
About Ang Cui
Ang Cui is a Postdoctoral Researcher at the Broad Institute of MIT and Harvard, specializing in computational biology and experimental immunology. With over a decade of experience in systems immunology research, he focuses on developing immune-based therapies and vaccines through a big-data approach.
Work at Broad Institute
Ang Cui has been working at the Broad Institute of MIT and Harvard as a Postdoctoral Researcher since 2021. In this role, he focuses on developing new immune-based therapies and vaccines, utilizing a big-data approach. Prior to this position, he served as a Graduate Research Fellow at the same institute from 2016 to 2021, gaining extensive experience in systems immunology research.
Education and Expertise
Ang Cui holds a Doctor of Philosophy (Ph.D.) from Harvard Medical School, which he completed from 2015 to 2021. He also earned a Master’s Degree (M.Sc.) from Yale University. His educational background includes a Bachelor of Applied Science (B.A.Sc.) in Engineering Science from the University of Toronto and a high school diploma from Harbord Collegiate Institute. His expertise spans computational biology and experimental immunology.
Background in Research
Ang Cui has a diverse background in research, having worked in various capacities at prestigious institutions. He was a Research Assistant at Yale University School of Medicine from 2013 to 2015 and at Harvard University for two months in 2012. Additionally, he worked as a Research Assistant at the University of Toronto from 2009 to 2012 and at The Julius Maximilians University of Würzburg in 2010.
Professional Experience
Ang Cui's professional experience includes roles outside of academia. He worked as a Biomedical Engineer at LV Prasad Eye Institute in Hyderabad for one month in 2016 and as a Software Engineer at Altera from 2011 to 2012. His early training as a computer engineer with a focus on machine learning complements his extensive research experience.
Years of Experience in Immunology
Ang Cui has over 10 years of experience in systems immunology research. His work primarily involves the development of immune-based therapies and vaccines, highlighting his commitment to advancing the field through innovative research methodologies.